AbbVie (NYSE:ABBV) Shares Up 3.4% – Time to Buy?
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) traded up 3.4% during mid-day trading on Friday . The stock traded as high as $253.35 and last traded at $251.52. 52,480,576 shares traded hands during trading, an increase of 636% from the average daily volume of 7,134,102 shares. The stock had previously closed at $243.14. […]
Fortinet, Inc. (NASDAQ:FTNT) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Fortinet, Inc. (NASDAQ:FTNT – Get Free Report) have been assigned a consensus rating of “Hold” from the thirty-six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating, twenty-five have issued a hold rating, six have issued a buy rating and one […]
Red Cat Holdings, Inc. (NASDAQ:RCAT) Receives Average Rating of “Buy” from Brokerages
Shares of Red Cat Holdings, Inc. (NASDAQ:RCAT – Get Free Report) have earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a buy recommendation and two have issued a strong […]
AbbVie Inc. (NYSE:ABBV) Receives Consensus Recommendation of “Moderate Buy” from Analysts
AbbVie Inc. (NYSE:ABBV – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-five ratings firms that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation, sixteen have issued a buy recommendation and three have given a strong buy recommendation to […]
Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR) Receives $19.28 Consensus Price Target from Analysts
Shares of Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The […]
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and […]
Royal Bank Of Canada (NYSE:RY) Receives Consensus Rating of “Moderate Buy” from Brokerages
Royal Bank Of Canada (NYSE:RY – Get Free Report) (TSE:RY) has received a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy […]
STMicroelectronics N.V. (NYSE:STM) Given Average Recommendation of “Moderate Buy” by Analysts
STMicroelectronics N.V. (NYSE:STM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. The […]
Johnson & Johnson (NYSE:JNJ) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Johnson & Johnson (NYSE:JNJ – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-seven ratings firms that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a hold rating and twenty have issued a buy rating on the company. The average 12 month price target […]
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and fourteen have given a buy recommendation […]
last updated on 29 Jun 05:40